INTERVENTIONAL NEUROLOGY: CEREBRAL ANEURYSM AND ARTERIOVENOUS MALFORMATION EMBOLIZATION SYSTEMS | GLOBAL MARKETS

68 Pages | 39 Exhibits | 2018 Analysis | Forecasts Through 2022 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for cerebral aneurysm and arteriovenous malformation embolization systems. This market includes endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel and emerging embolization devices.

NEUROLOGY MARKET HIGHLIGHTS

  • The global market for cerebral aneurysm and AVM embolization systems totalled nearly $1.0bn in 2017, with embolic coils accounting for the largest share of sales.
  • From 2017-22, the value of the market is projected to increase at a CAGR of 3.9%, reaching nearly $1.2bn in 2022.
  • The greatest growth is projected for the flow diversion market segment.
  • Leading competitors in the market for cerebral embolization systems include Johnson & Johnson, Medtronic, and Stryker, among others.
KEY QUESTIONS ANSWERED
  • What are the key drivers and limiters for the market?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the market are experiencing dynamic growth?
  • How are mergers and acquisitions affecting the market shares of leading competitors?


TABLE OF CONTENTS:
Executive Summary 

i. Embolization systems
	a. Embolic coiling 
	b. Liquid embolics
	c. Neuroendovascular stents for stent-assisted coiling
	d. Flow diversion, flow disruption, and other embolic systems
ii. Combined market forecast
	a. Market leaders
iii. Methodology

Exhibit ES-1: Embolization systems for treatment of cerebral aneurysms and AVMs, combined market forecast ($m), by region, 2017-22

1. Clinical Overview
 
1.1 Intracerebral hemorrhage
1.2 Subarachnoid hemorrhage
1.3 Cerebral aneurysm 
1.4 Arteriovenous malformations
1.5 Repair of cerebral aneurysms and AVMs
	1.5.1 Surgical clipping 
	1.5.2 Endovascular embolization
	1.5.3 Stent-assisted coiling 
	1.5.4 Flow diversion
	1.5.5 ARUBA clinical trial
1.6 Bibliography

Exhibit 1-1: Clinical features and characteristics of hemorrhagic stroke
Exhibit 1-2: Global incidence and prevalence, by gender, hemorrhagic stroke, absolute number, in millions, 1990 and 2013
Exhibit 1-3: Illustration of an embolic coil procedure for cerebral aneurysms
Exhibit 1-4: Illustration of an endovascular embolization procedure for arteriovenous malformations

2. Neuroendovascular Embolization Products

2.1 Microcoil embolization products
2.2 Liquid embolics
2.3 Stent products for wide-neck aneurysms
2.4 Flow diversion devices
2.5 Flow disruption and other novel/emerging aneurysm embolization devices 
2.6 Current clinical trials
2.7 Bibliography

Exhibit 2-1: Advantages and disadvantages of cerebral aneurysm clipping versus coiling procedures 
Exhibit 2-2: Selected neuroendovascular aneurysm microcoils, 2018
Exhibit 2-3: Selected liquid embolics, 2018
Exhibit 2-4: Selected neuroendovascular stents for the treatment of wide-neck aneurysms 
Exhibit 2-5: Selected flow diversion devices, 2018 
Exhibit 2-6: Selected flow disruption and other novel embolic systems, 2018 
Exhibit 2-7: Selected clinical trials of neuroendovascular embolic systems for aneurysms and AVMs, 2018

3. Market for Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems
 
3.1 Combined market forecast
3.2 Combined procedure volumes forecast
3.3 Combined competitive analysis
3.4 Embolic coiling
	3.4.1 Procedure volumes forecast
	3.4.2 Market forecast 
	3.4.3 Competitive analysis
3.5 Liquid embolics
	3.5.1 Procedure volumes forecast
	3.5.2 Market forecast 
	3.5.3 Competitive analysis
3.6 Neuroendovascular stents for stent-assisted coiling 
	3.6.1 Procedure volumes forecast
	3.6.2 Market forecast 
	3.6.3 Competitive analysis
3.7 Flow diversion, flow disruption, and other embolic systems
	3.7.1 Procedure volumes forecast
	3.7.2 Market forecast 
	3.7.3 Competitive analysis
3.8 Bibliography

Exhibit 3-1: Embolization systems for treatment of cerebral aneurysms and AVMs, combined market forecast ($m), by region, 2017-22 
Exhibit 3-2: Embolization systems for treatment of cerebral aneurysms and arteriovenous malformations, share of revenues by region, 2017
Exhibit 3-3: Cerebral aneurysm and AVM embolization systems, combined market forecast ($m), by product segment, 2017-22
Exhibit 3-4: Neuroendovascular embolization, procedure volumes forecast, by type of embolic system used, 2017-22
Exhibit 3-5: Neuroendovascular embolization procedures, combined procedure volumes forecast, 2017-22
Exhibit 3-6: Neuroendovascular embolization procedure volumes, share by country/region, 2017
Exhibit 3-7: Cerebral aneurysm and AVM embolization system sales, share by supplier, 2017 
Exhibit 3-8: Embolic coiling, procedure volumes forecast, by region, 2017-22
Exhibit 3-9: Embolic coiling procedure volumes, share by country/region, 2017 
Exhibit 3-10: Neuroendovascular coiling systems, market forecast ($m), 2017-22
Exhibit 3-11: Neuroendovascular coiling systems market, share by region, 2017 
Exhibit 3-12: Neuroendovascular coiling systems market, share by supplier, 2017
Exhibit 3-13: Neuroendovascular liquid embolization, procedure volumes forecast, by region, 2017-22 
Exhibit 3-14: Neuroendovascular liquid embolization procedures, share by region, 2017 
Exhibit 3-15: Neuroendovascular liquid embolics, market forecast ($m), by region, 2017-22 
Exhibit 3-16: Neuroendovascular liquid embolics market, share by region, 2017
Exhibit 3-17: Neuroendovascular liquid embolics market, share by supplier, 2017
Exhibit 3-18: Neuroendovascular stent-assisted coiling, procedure volumes forecast, share by region, 2017-22
Exhibit 3-19: Neuroendovascular stent assist coiling procedures, share by region, 2017
Exhibit 3-20: Coil-containment stents for intracranial applications, market forecast ($m), by region, 2017-22 
Exhibit 3-21: Market for coil-containment stents for intracranial applications, share by country/region, 2017
Exhibit 3-22: Market for coil-containment stents for intracranial applications, share by supplier, 2017 
Exhibit 3-23: Flow diversion and other embolization procedures, procedure volumes forecast, by country/region, 2017-22
Exhibit 3-24: Flow diversion and other embolization procedures, share by country/region, 2017
Exhibit 3-25: Flow diversion and other newly developed embolization systems, market forecast ($m), by country/region, 2017-22 
Exhibit 3-26: Market for flow diversion and other embolization products, share by country/region, 2017
Exhibit 3-27: Market for flow diversion and other embolization products, share by supplier, 2017
 
APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Acandis
  2. Balt International
  3. Blockade Medical
  4. Cerenovus
  5. Cerus Endovascular
  6. Embo-Flussigkeiten
  7. Evasc
  8. GEM
  9. Johnson & Johnson
  10. Medtronic
  11. Microport
  12. Microvention
  13. Penumbra
  14. Phenox
  15. Rapid Medical
  16. Stryker
  17. Terumo
  18. Zhuhai Tonbridge Medical Technology
Contact Us

Need help finding medtech research? Let us help you!